Skip to main content

Peer Review reports

From: Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study

Original Submission
26 Jul 2021 Submitted Original manuscript
1 Aug 2021 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 2
1 Aug 2021 Submitted Manuscript version 2
6 Aug 2021 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 3
6 Aug 2021 Submitted Manuscript version 3
6 Sep 2021 Reviewed Reviewer Report
9 Sep 2021 Reviewed Reviewer Report
17 Sep 2021 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 4
17 Sep 2021 Submitted Manuscript version 4
25 Oct 2021 Reviewed Reviewer Report
30 Dec 2021 Reviewed Reviewer Report
14 Jan 2022 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 5
14 Jan 2022 Submitted Manuscript version 5
24 Jan 2022 Reviewed Reviewer Report
7 Feb 2022 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 6
7 Feb 2022 Submitted Manuscript version 6
16 Feb 2022 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 7
16 Feb 2022 Submitted Manuscript version 7
19 Mar 2022 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 8
19 Mar 2022 Submitted Manuscript version 8
23 Mar 2022 Author responded Author comments - Elisa Ochfeld
Resubmission - Version 9
23 Mar 2022 Submitted Manuscript version 9
Publishing
24 Mar 2022 Editorially accepted
9 May 2022 Article published 10.1186/s41927-022-00265-z

You can find further information about peer review here.

Back to article page